GL1X · GenesisL1 explorer

MolNFT v1 · #63073 · protein

Crystal structures of JAK1 and JAK2 inhibitor complexes

3EYG · Tyrosine-protein kinase: “Crystal structures of JAK1 and JAK2 inhibitor complexes”. X-ray diffraction, 1 ligand (MI1), 2 pockets (best druggability 0.63). MolNFT v1 #63073 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
3EYG
Type
protein
Length
282 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase
EC
2.7.10.2
UniProt
Q59GQ2
Ligands
MI1
Pockets
2 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase (EC 2.7.10.2)protein28241% helix, 20% strandQ59GQ2

Ligands and binding sites

  • MI1 · 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12090.630.8328MI1
2820.450.8018empty

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 3EYG · Crystal structures of JAK1 and JAK2 inhibitor complexes · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.